维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Willenberg HS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The serum sodium to urinary sodium to ( serum potassium) 2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism 显示文摘	Willenberg HS Kolentini C Quinkler M	2009	Eur J Clin Invest2009，39，1：	1
2	Dendritic cells as potential adjuvant for immunotherapy in adrenocortical carcinoma显示文摘	Papewalis C Fassnacht M Willenberg HS	2006	Clin Endocrinol (Oxf)2006，65，2：	1
3	Serum sele- nium levels in patients with remission and relapse of graves' disease 显示文摘	Wertenbruch T Willenberg HS Sagert C	2007	Med Chem2007，3，3：	1
4	Serum selenium levels in patients with remission and relapse of Graves' disease显示文摘	Wertenbruch T Willenberg HS Sagert C	2007	Medicinal Chemistry2007，3，3：	1
5	Serum selenium levels in patients with remission and relapse of Graves'disease显示文摘	Wertenbruch T Willenberg HS Sagert C	2007	Medicinal Chemistry2007，3，3：	1
6	Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway显示文摘	Schinner S Willenberg HS Krause D	2007	Int J Obes (Lond)2007，31，5：	1
7	Adrenal pheochromocytoma with contralateral cortisol-producing adrenal adenoma:diagnostic and therapeutic management显示文摘	Wolf A Willenberg HS Cupisti K	2005	Rm Metab Res2005，37，6：	1
8	Serum selenium levels in patients with remission and relapse of Graves' disease 显示文摘	Wertenbruch T Willenberg HS Sagert C	2007	Medicinal Chemistry2007，3，3：	1
9	Serum selenium levels in patients with remission and relapse of Graves' disease显示文摘	Wertenbruch T Willenberg HS Sagert C	2007	Medicinal Chemistry2007，3，3：	1
10	The serum sodi um to urinary sodium to (serum potassium)2 to urirtary potassium (SUSPPUP) ratio in patients with primary aldosteronism显示文摘	Willenberg HS Kolentini C Quinkler M	2009	European Journal of Clinical Investigation2009，39，1：	1
11	Seleniumto selenoproteins levels in patients with remission and relapse ofGraves'disease显示文摘	Wertenburch T Willenberg HS Sagert C	2007	Med Chem2007，3，3：	1
12	Expression of connexins in chromaffin cells of normal human adrenals and in benign and malignant pheochromocytomas显示文摘	Willenberg HS Schott M Saeger W	2006	Ann N Y Acad Sci2006，1073，8：	1
13	Serum selenium levelsin patients with remission and relapse of Graves' disease显示文摘	Wertenbruch T Willenberg HS Sagert C	2007	Med Chem2007，3，3：	1
14	Adipocyte - derivedproducts induce the transcription of the StAR promoter and stimulate al-dosterone and cortisol secretion from adrenocortical cells through theWnt - signaling pathway 显示文摘	Schinner S Willenberg HS Krause D	2007	Int J Obes (Lond)2007，31，5：	1
15	Ectopic adrenocorticotropin(ACTH) and corticotropin-releasing hormone(CRH) production in the adrenal gland: basic and clinical aspects显示文摘	Vrezas I Willenberg HS Mansmann G	2003	Microsc Res Tech2003，61，3：	1
16	Adipocyte-secreted fact- ors increase osteoblast proliferation and the OPG/RANKL ratio to inf- luence osteoclast formation 显示文摘	Ku hn MC Willenberg HS Schott M	2011	Molecular and Cellular Endocrinol- ogy2011，27，6：	1
17	Improved predic-tion of relapse of Graves' thyrotoxicosis by combined deter-mination of TSH receptor and thyroperoxidase antibodies 显示文摘	Schott M Eckstein A Willenberg HS	2007	Horm Metab Res2007，39，1：	1
18	Relevance ofTSH receptor stimulating and blocking autoantibody measure-ment for the prediction of relapse in Graves' disease 显示文摘	Schott M Minich WB Willenberg HS	2005	HormMetab Res2005，37，12：	1
19	Serum selenium levels in patients with remission and relapse of graves' disease显示文摘	Wertenbruch T Willenberg HS Sagert C		0，，：	1
20	Pathophysiologicall aspects of Wnt-signaling in endocrine disease 显示文摘	Schinner S Willenberg HS Schott M	2009	Horm Metab Res2009，41，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示